Funding Support and Author Disclosures Dr Coylewright has received research funding from Edwards LifeSciences and Boston Scientific; has received honoraria from Edwards LifeSciences, Boston Scientific, Medtronic, and Occlutech; and leads the global Eligibility Review Committee for the EXPAND II trial. Dr Januzzi is a Trustee of the American College of Cardiology; is a board member of Imbria Pharmaceuticals; is a Director at Jana Care; has received grant support from Abbott, Applied Therapeutics, HeartFlow, Innolife, Medtronic, and Roche Diagnostics; has received consulting income from Abbott, Beckman, Bristol Myers Squibb, Boehringer Ingelheim, Janssen, Novartis, Pfizer, Merck, Roche Diagnostics, and Siemens; participates in clinical endpoint committees/data safety monitoring boards for Abbott, AbbVie, CVRx, Eidos, Intercept, and Takeda; and serves on the global Eligibility Review Committee for the EXPAND II trial. Dr Szerlip is a speaker and proctor for Edwards LifeSciences, Boston Scientific, and Abbott; is on the advisory board for Boston Scientific; and is on steering committees for Medtronic and Abbott.